🇺🇸 FDA
Patent

US 9045559

Method for screening inhibitors of interleukin-32 (IL-32)

granted A61PA61P29/00A61P37/02

Quick answer

US patent 9045559 (Method for screening inhibitors of interleukin-32 (IL-32)) held by The Regents of the University of Colorado expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P29/00, A61P37/02, A61P43/00